Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongmin Tang

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|August 30, 2014
Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8bDiying Shen, Yongmin Tang, Sisi Li, et al.
Journal of Drug Targeting|April 21, 2011
3A4, a new potential target for B and myeloid lineage leukemiasSisi Li, Yongmin Tang, Jingying Zhang, et al.
DNA and Cell Biology|August 11, 2018
Construction, Expression, and Characterization of a Novel Human-Mouse Chimeric Antibody, Hm3A4: A Potential Therapeutic Agent for B and Myeloid Lineage LeukemiasSisi Li, Diying Shen, Xiaoping Guo, et al.
Oncology Letters|February 20, 2013
Simultaneous cytomorphological and multiparameter flow cytometric analysis of ALK-positive anaplastic large cell lymphoma in childrenHongqiang Shen, Yongmin Tang, Xiaojun Xu, et al.
International Journal of Laboratory Hematology|December 14, 2020
U2AF1 expression is a novel and independent prognostic indicator of childhood T-lineage acute lymphoblastic leukemiaPing Zhang, Yao Zhang, Xiaoxiao Li, et al.
Journal of Pediatric Hematology/Oncology|May 1, 2024
Combined Use of Emapalumab With Ruxolitinib and Dexamethasone as an Effective Treatment for Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis Complicated With Multiorgan Damage and Severe InfectionJuan Liang, Xiaojun Xu, Zhenjie Chen, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 27, 2023
Exploratory study on the efficacy of bortezomib combining mitoxantrone or CD22-CAR T therapy targeting CD19-negative relapse after CD19-CAR T cell therapy with a simpler cell-line-based modelDiandian Ba, Hongzhe Li, Rongrong Liu, et al.
Journal of Drug Targeting|March 13, 2010
Targeting of the B-lineage leukemia stem cells and their progeny with norcantharidin encapsulated liposomes modified with a novel CD19 monoclonal antibody 2E8 in vitroJingying Zhang, Yongmin Tang, Sisi Li, et al.
Journal of Drug Targeting|June 20, 2017
The targeting effect of Hm2E8b-NCTD-liposomes on B-lineage leukaemia stem cells is associated with the HLF-SLUG axisJingying Zhang, Diying Shen, Min Jia, et al.
Oncology Letters|July 12, 2012
Cloning and sequencing of the light chain variable region from NS-1 myelomaBotao Ning, Yongmin Tang, Hua Song, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|August 30, 2014
Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8bDiying Shen, Yongmin Tang, Sisi Li, et al.
Journal of Drug Targeting|April 21, 2011
3A4, a new potential target for B and myeloid lineage leukemiasSisi Li, Yongmin Tang, Jingying Zhang, et al.
DNA and Cell Biology|August 11, 2018
Construction, Expression, and Characterization of a Novel Human-Mouse Chimeric Antibody, Hm3A4: A Potential Therapeutic Agent for B and Myeloid Lineage LeukemiasSisi Li, Diying Shen, Xiaoping Guo, et al.
Oncology Letters|February 20, 2013
Simultaneous cytomorphological and multiparameter flow cytometric analysis of ALK-positive anaplastic large cell lymphoma in childrenHongqiang Shen, Yongmin Tang, Xiaojun Xu, et al.
International Journal of Laboratory Hematology|December 14, 2020
U2AF1 expression is a novel and independent prognostic indicator of childhood T-lineage acute lymphoblastic leukemiaPing Zhang, Yao Zhang, Xiaoxiao Li, et al.
Journal of Pediatric Hematology/Oncology|May 1, 2024
Combined Use of Emapalumab With Ruxolitinib and Dexamethasone as an Effective Treatment for Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis Complicated With Multiorgan Damage and Severe InfectionJuan Liang, Xiaojun Xu, Zhenjie Chen, et al.
Apoptosis : an International Journal on Programmed Cell Death|May 27, 2023
Exploratory study on the efficacy of bortezomib combining mitoxantrone or CD22-CAR T therapy targeting CD19-negative relapse after CD19-CAR T cell therapy with a simpler cell-line-based modelDiandian Ba, Hongzhe Li, Rongrong Liu, et al.
Journal of Drug Targeting|March 13, 2010
Targeting of the B-lineage leukemia stem cells and their progeny with norcantharidin encapsulated liposomes modified with a novel CD19 monoclonal antibody 2E8 in vitroJingying Zhang, Yongmin Tang, Sisi Li, et al.
Journal of Drug Targeting|June 20, 2017
The targeting effect of Hm2E8b-NCTD-liposomes on B-lineage leukaemia stem cells is associated with the HLF-SLUG axisJingying Zhang, Diying Shen, Min Jia, et al.
Oncology Letters|July 12, 2012
Cloning and sequencing of the light chain variable region from NS-1 myelomaBotao Ning, Yongmin Tang, Hua Song, et al.
Pageof 8